rodriguez2024-05-23T07:19:16-06:00InDevR Raises $7 million in Series A Financing with Adjuvant Capitalrodriguez2024-05-23T07:19:16-06:00September 10th, 2019|
rodriguez2024-05-23T07:19:48-06:00Clinical validation of the FluChip-8G Influenza A+B Assay for influenza type and subtype identification published in Journal of Clinical Virologyrodriguez2024-05-23T07:19:48-06:00August 6th, 2019|
rodriguez2024-05-23T07:20:02-06:00Analytical Evaluation of the Microarray-Based FluChip-8G Influenza A+B Assay published in Journal of Virological Methodsrodriguez2024-05-23T07:20:02-06:00August 6th, 2019|
rodriguez2024-05-23T07:24:16-06:00510(k) Market Clearance for FluChip-8G Influenza A+B Assayrodriguez2024-05-23T07:24:16-06:00April 30th, 2019|
rodriguez2024-05-23T07:23:57-06:00[Press Release] InDevR Chosen for NIH’s Innovation Zone at BIO International Conventionrodriguez2024-05-23T07:23:57-06:00April 4th, 2019|
